Miyazaki et al., using an in vitro model of cellular resistance to Lenvatinib and spheroids of the HCC cells line, showed that the EGFR-PI3K-AKT signaling pathway is involved in Lenvatinib resistance, and curcumin was able to suppress this signaling pathway. Here, AKT1 is linked to hepatocellular carcinoma.